ATP-competitive inhibitor of IGF1R (IC50 in the range of 0.1-0.2 μM)
Also inhibits c-Kit kinase activity (IC50 in the range of 3-5 μM)
Exhibits a synergistic effect with Imatinib, enhancing the sensitivity of multiple small cell lung cancer cell lines to the chemotherapeutics etoposide (Cat